Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Peking University Cancer Hospital & Institute
Institut Paoli-Calmettes
University Hospital, Essen
Asan Medical Center
Centre Hospitalier Universitaire Vaudois
Guangxi Medical University
Panolos Bioscience
Universitair Ziekenhuis Brussel
Shandong Provincial Hospital
Zhejiang University
University of Maia
Celon Pharma SA
Aurigene Discovery Technologies Limited
Henan Cancer Hospital
First People's Hospital of Hangzhou
RenJi Hospital
Hebei Medical University
Fujian Cancer Hospital
Chongqing Precision Biotech Co., Ltd
Kidney Cancer Research Bureau
RemeGen Co., Ltd.
RemeGen Co., Ltd.
National Cheng-Kung University Hospital
Icahn School of Medicine at Mount Sinai
Ajou University School of Medicine
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Base Therapeutics (Shanghai) Co., Ltd.
Massachusetts General Hospital
Hebei Medical University
Minneamrita Therapeutics LLC
Shanghai East Hospital
Jinling Hospital, China
Zhongnan Hospital
Rutgers, The State University of New Jersey
Zhejiang Cancer Hospital
RenJi Hospital
RenJi Hospital
Sun Yat-sen University
Assaf-Harofeh Medical Center
National University Hospital, Singapore
Zuyderland Medisch Centrum
Amsterdam UMC, location VUmc
The Affiliated Hospital of Qingdao University
Sichuan University
Tang-Du Hospital
Kineta Inc.
Tianjin Medical University Cancer Institute and Hospital
Peking Union Medical College Hospital
Tianjin Medical University Cancer Institute and Hospital